SK Biopharmaceuticals to In-License Epilepsy Drug Candidate 'Opakalim
Paves the Way to Launch its Second Innovative Drug Directly in the U.S.Announces agreement to in-license near-commercial candidate at a press conferenceTargets U.S. commercial launch...